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Abstract The aims of this study were to investigate the
usefulness of serum C-reactive protein, procalcitonin, tumor
necrosis factor alpha, interleukin-6, and interleukin-8 as
postmortem markers of sepsis and to compare C-reactive
protein and procalcitonin values in serum, vitreous humor,
and cerebrospinal fluid in a series of sepsis cases and
control subjects, in order to determine whether these
measurements may be employed for the postmortem
diagnosis of sepsis. Two study groups were formed, a
sepsis group (eight subjects coming from the intensive care
unit of two university hospitals, with a clinical diagnosis of
sepsis in vivo) and control group (ten autopsy cases
admitted to two university medicolegal centers, deceased
from natural and unnatural causes, without elements to
presume an underlying sepsis as the cause of death). Serum
C-reactive protein and procalcitonin concentrations were
significantly different between sepsis cases and control
cases, whereas serum tumor necrosis factor alpha,
interleukin-6, and interleukin-8 values were not significant-
ly different between the two groups, suggesting that
measurement of interleukin-6, interleukin-8, and tumor
necrosis factor alpha is non-optimal for postmortem
discrimination of cases with sepsis. In the sepsis group,
vitreous procalcitonin was detectable in seven out of eight
cases. In the control group, vitreous procalcitonin was
clearly detectable only in one case, which also showed an
increase of all markers in serum and for which the cause of
death was myocardial infarction associated with multi-
organic failure. According to the results of this study, the
determination of vitreous procalcitonin may be an alterna-
tive to the serum procalcitonin for the postmortem
diagnosis of sepsis.
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Introduction
The term sepsis is used to define the systemic inflammatory
response to an infectious agent (i.e., bacterial, viral, fungal,
or parasitic). Despite the use of new treatment modalities,
improvement in technology, and increased experience, the
sepsis mortality rate remains high [1].
Sepsis can be difficult to distinguish from other
noninfectious systemic inflammatory responses in critically
ill patients admitted to the hospital with clinical signs of
acute inflammation. Thus, there is an unmet need for
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clinical or laboratory tools distinguishing between the
systemic inflammatory response syndrome and the various
forms of sepsis [2].
In the forensic routine, sepsis as cause of death remains
difficult to diagnose due to insufficient or absent medical
information at the moment of the autopsy, contaminated
blood or tissue, nonspecific autopsy findings (myocardial
ischemia, pulmonary edema, hypoxic liver damage, mes-
enteric ischemia, gastrointestinal hemorrhages, spleen
infarction, kidney ischemia, and brain edema) as well as
histological observations, which may in effect have an
infectious or noninfectious origin and are neither specific
nor sensitive for recognizing sepsis-related fatalities [3–5].
Immunohistochemical detection of molecules of interest
such as chemokine receptors, integrins, and intercellular
adhesion molecules has been proposed as valuable diag-
nostic tools for the postmortem diagnosis of sepsis [6–8].
However, other parameters are needed to clearly establish a
postmortem diagnosis of sepsis [8].
A large number of clinical studies have been performed
in the last decades to correlate cytokines levels with sepsis
and patient prognosis. Among the potentially useful sepsis
markers, tumor necrosis factor alpha (TNF-α), interleukin 2
(IL-2), interleukin 6 (IL-6), interleukin 8 (IL-8), and
interleukin-10 (IL-10) have been proposed to be the most
promising candidates [1, 2, 9].
Harbarth et al. investigated the diagnostic value of
procalcitonin, IL-6, and IL-8 in a group of severely ill
patients admitted to hospital with signs of acute inflamma-
tion in order to assess whether these markers were helpful
in distinguishing sepsis from severe systemic noninfectious
inflammations. They found that procalcitonin was the best
indicator of infection in newly admitted critically ill
patients, whereas measurement of IL-6 and IL-8 was non-
optimal for discriminating patients with infectious from
those with noninfectious diseases [2].
Balci et al. investigated the procalcitonin levels at early
diagnosis and differentiation in patients with systemic
inflammatory response syndrome and sepsis, in comparison
with C-reactive protein (CRP), TNF-α, IL-2, IL-6, and IL-
8, in an unselected population of patients admitted to an
intensive care unit and suffering from a broad range of
diseases. Their results showed that procalcitonin was a
more accurate marker for differentiating between patients
suffering from systemic inflammatory response syndrome
and those with sepsis [1].
Heper et al. evaluated serum CRP, procalcitonin, TNF-α,
and IL-10 levels within the first 72 h of admission to
hospital in patients with community-acquired sepsis, severe
sepsis, and septic shock, in order to determine the
diagnostic value of these markers in differentiating sepsis
from severe sepsis, especially at the early stages and
establish their prognostic value in predicting the outcome
at admission. They found that procalcitonin and IL-10 were
more useful in discriminating between sepsis and severe
sepsis, whereas TNF-α and IL-10 were more useful in
predicting which cases were likely to have a fatal outcome
[9].
In forensic practice, several authors focused on the use
of serum procalcitonin, CRP, and IL-6 for the postmortem
discrimination between sepsis and non-septic underlying
causes of death. In this study, we investigated serum CRP,
procalcitonin, TNF-α, IL-6, and IL-8 in a series of sepsis-
related fatalities and control subjects in order to evaluate
their usefulness as postmortem markers of sepsis. We also
compared CRP and procalcitonin values in serum, vitreous
humor, and cerebrospinal fluid in a series of sepsis-related
fatalities and control subjects in order to determine their
applicability in the postmortem diagnosis of death due to
sepsis.
Materials and methods
Subjects
Two study groups were formed (sepsis group and control
group) according to whether there was an underlying
clinical diagnosis of sepsis as the cause of death based on
the medical records as well as on the autopsy findings. The
sepsis group (n=8, males, individual ages 4–78 years old,
mean age 46 years) consisted of eight subjects, from the
intensive care unit of two university hospitals, with a well-
documented previous history and clinical diagnosis of
sepsis in vivo according to the definition of the American
College of Chest Physicians/Society of the Critical Care
Medicine Consensus Conference [10], confirmed by post-
mortem examination. The period of septic condition was
between 2 and 6 days. The cause of death was multiple
organ failure due to sepsis in all cases. Postmortem
microbiological investigations performed on cardiac blood
revealed the presence of Klebsiella pneumoniae (two
cases), Escherichia coli (two cases), and Staphylococcus
aureus (one case). In three cases, postmortem microbiolog-
ical investigation revealed no clearly identifiable pathogens.
The non-sepsis group (n=10, eight males, two females,
individual ages 17–69 years old, mean age 44 years)
consisted of ten autopsy cases, from two university
medicolegal centers, with death due to various natural
(myocardial infarction and myocardial insufficiency) and
unnatural (hanging, electrocution, trauma, intoxication)
causes. No individuals in this study group had medical
history of septic condition prior to death, and no other
disease was found at the autopsy except for the cause of
death (myocardial infarction n=2, myocardial insufficiency
n=2, trauma n=1, intoxication n=3, electrocution n=1, and
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hanging n=1). Cardiopulmonary resuscitation was attemp-
ted in eight cases. In none of these cases the autopsy
findings gave any element suggesting an underlying
infectious disease, and no postmortem microbiological
investigation was carried out.
Samples collection
Serum samples
Postmortem blood samples were collected by aspiration
with a sterile needle and a syringe from the femoral vein at
defined time intervals between 2 and 72 h postmortem from
the individuals included in both study groups. All blood
samples were centrifuged immediately after collection at
1,500 rpm for 15 min. After centrifugation, the serum was
frozen at −20°C.
Vitreous humor samples
Postmortem vitreous humor samples were collected by
aspiration using a sterile needle and a syringe. Right and left
vitreous humor samples were collected before autopsy
through a scleral puncture at the lateral canthus and mixed
together. All vitreous samples were centrifuged immediately
after collection at 1,500 rpm for 15 min. After centrifugation,
the samples were frozen at −20°C.
Cerebrospinal fluid samples
Cerebrospinal fluid samples were collected by aspiration
using a sterile needle and a syringe by suboccipital
puncture. All cerebrospinal fluid samples were immediately
frozen after collection at −20°C.
Analysis
Determination of C-reactive protein
SYNCHRON® C-Reactive Protein Reagent (Beckman
Coulter, Inc., Brea, USA) was used to measure CRP
concentration by a turbidimetric method according to the
supplier’s instructions. In the reaction, CRP combines with
a specific antibody to form insoluble antigen–antibody
complexes. SYNCHRON systems automatically proportion
the appropriate sample and reagent volumes into a cuvette,
one part sample to 26 parts reagent. The system monitors
the change in absorbance at 340 nm. This change in
absorbance is proportional to the concentration of CRP in
the sample and is used by the systems to calculate and
express CRP concentration, based upon a multipoint,
nonlinear calibration curve. Results were expressed in
milligrams per liter. A value greater than 10 mg/l was
considered to be elevated.
Determination of procalcitonin
KRYPTOR® (B·R·A·H·M·S, Henningsdorf, Germany) was
used to measure procalcitonin concentration. KRYPTOR®
uses time-resolved amplified cryptate emission technology,
based on a non-radiative transfer of energy. This transfer
takes place between two fluorescent tracers: europium
cryptate (donor) and XL665 (acceptor). The signal mea-
sured during the formation of the antigen–antibody com-
plex is accompanied by amplification. KRYPTOR® assays
are homogeneous, without separation or washing. The
molecules of procalcitonin present in the assay samples
are sandwiched between the antibodies. The intensity of the
signal is proportional to the amount of procalcitonin. The
shape of the standard curve is identical to that obtained by
immunometric methods. Results were expressed in nano-
grams per milliliter. A value lower than 0.25 ng/ml was
considered to be normal.
Determination of tumor necrosis factor alpha, interleukin-6,
and interleukin-8
TNF-α, IL-6, and IL-8 were measured by a commercially
available multiplex beads immunoassay, based on the
Luminex platform (Fluorokine MAP Multiplex Human
Cytokine Panel, R&D Systems, Minneapolis, USA) accord-
ing to supplier’s instructions. Briefly, beads with defined
spectral property were conjugated to the analyte-specific
capture antibodies. Beads, samples, standards, and the
controls were pipetted in a filter-bottomed 96-well plate
and incubated at room temperature for 3 h while gently
shaking. After three washes, the biotinylated detector
antibody cocktail was added to the wells and incubated
for 1 h at room temperature. Streptavidin conjugated with
R-phycoerythrin was added to the wells after several
washings and incubated for 30 min. The data (mean
fluorescence intensity) were then read by the Bio-Plex
200 array reader (Bio-Rad Laboratories, Hercules, CA, U.S.
A.) which uses Luminex xMAP™ Technology (Luminex
Corporation, Austin, TX, U.S.A.). Sample concentrations
were calculated using standard curves. Results were
expressed in picograms per milliliter.
Statistical method
Means, standard deviations (SD), medians, minimum and
maximum values were reported for each group. Observed
values were plotted, and normal distribution was assessed
measuring skewness and kurtosis. As distribution was
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skewed, differences between sepsis and control group for
serum procalcitonin, CRP, TNF-α, IL-6, and IL-8 were
compared using nonparametrical Mann–Whitney U test.
The significance level was set at 0.05. Correlations between
serum, vitreous humor and cerebrospinal fluid were tested
using Spearman’s correlation coefficient.
Results
Individual serum procalcitonin, CRP, TNF-α, IL-6, and IL-
8 values are reported in Fig. 1. Values were skewed and
cannot be considered as normally distributed. Individual
procalcitonin and CRP values in the vitreous humor and in
the cerebrospinal fluid for sepsis cases and control cases are
reported in Table 1.
Serum CRP levels were elevated in all sepsis cases, with
values varying from 23 to 272 mg/l, whereas serum
procalcitonin levels were elevated in seven out of eight
cases, with values varying from 0.03 to 218 ng/ml.
Most sepsis cases also showed high values of serum
TNF-α (six cases out of eight, with values varying from
2.92 to 249 pg/ml), whereas serum IL-6 and IL-8 levels
were elevated in all sepsis cases (with values varying from
81 to 75,296 pg/ml for IL-6 and from 79 to 3,115 pg/ml for
IL-8).
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Fig. 1 Individual serum values of a CRP, b PCT, c TNF-α, d IL-6, and e IL-8
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In the control group, serum procalcitonin levels were
lower than 0.5 ng/ml in nine out of ten cases. In one case,
the serum procalcitonin value was 27.75 ng/ml. The same
case showed high values of CRP (150 mg/l), TNF-α
(13.86 pg/ml), IL-6 (6,798 pg/ml), and IL-8 (371 pg/ml).
The cause of death in this case was myocardial insufficien-
cy associated with multi-organic failure. The autopsy
findings did not give any element to suspect an underlying
infectious disease, even if an infection obviously cannot be
totally excluded.
Serum CRP levels in the control group were lower than
15 mg/l in nine cases out of ten (one case showed a
concentration of 150 mg/l, as previously reported). Serum
TNF-α values varied in the control group from 0.1 to
586 pg/ml, serum IL-6 from 16 to 112,404 pg/ml, and
serum IL-8 from 0 to 399 pg/ml.
In the sepsis group, CRP values in the vitreous and in the
cerebrospinal fluid varied from undetectable to 8 mg/l (for
vitreous) and from undetectable to 12 mg/l (for cerebrospi-
nal fluid). In the control group, CRP in the cerebrospinal
fluid was not detectable in eight out of ten cases; in the
vitreous humor, CRP was not detectable in nine out of ten
cases.
One case showed a CRP concentration in cerebrospinal
fluid of 4 mg/l and a CRP concentration in vitreous humor
of 1 mg/l. As expected, this case also showed high serum
procalcitonin, CRP, TNF-α, IL-6, and IL-8 values.
In the sepsis group, vitreous procalcitonin was detectable
in seven out of eight cases, with values varying from
undetectable (one case) to 0.85 ng/ml. In the cerebrospinal
fluid, procalcitonin values varied from undetectable (three
cases) to 24.65 ng/ml.
In the control group, procalcitonin values in the
cerebrospinal fluid were lower than 0.1 ng/ml in nine out
of ten cases, with only one case showing a value of 4.17 ng/
ml (the case that showed high values of all serum markers).
In the vitreous humor, procalcitonin levels were lower than
0.05 ng/ml, with only one case showing a value of 0.34 ng/
ml (the case that showed high values of all serum markers).
We noted significant differences between sepsis group
and control group for CRP (p=0.001) and procalcitonin
(p=0.016), but not for TNF-α, IL-6, and IL-8 (Table 2).
Procalcitonin also showed interesting correlations between
different biological fluids, especially for vitreous humor
(Table 3).
Discussion
In this study, we investigated serum CRP, procalcitonin,
TNF-α, IL-6, and IL-8 in a series of sepsis-related fatalities
and control subjects in order to evaluate their applicability
as postmortem markers of sepsis. A total of 18 cases (eight
sepsis-related fatalities and ten control cases) were included
in this study. According to our observations, serum CRP
and procalcitonin concentrations were significantly differ-
ent between sepsis cases and control subjects, whereas
serum TNF-α, IL-6, and IL-8 values were not significantly
Group Agent/cause of death Age (years) Vitreous humor Cerebrospinal fluid
CRP PCT CRP PCT
Sepsis K. pneumoniae 78 0 0.13 0 0.47
E. coli 28 1 0.19 5 0.22
– 38 0 0.22 12 0
– 39 0 0.85 2 4.06
S. aureus 66 2 0.68 0 0
E. coli 73 8 0.37 0 0
– 42 0 0 0 0.06
K. pneumoniae 4 0 0.84 1 24.65
Control Trauma 54 0 0 0 0.04
Intoxication 37 0 0 0 0.06
Hanging 54 0 0 0 0.07
Myocardial infarction 48 0 0 0 0.03
Intoxication 45 0 0.02 0 0.09
Myocardial insufficiency 35 0 0.04 0 0.05
Intoxication 34 0 0 0 0.1
Myocardial infarction 42 0 0 0 0.07
Myocardial insufficiency 32 1 0.34 4 4.17
Electrocution 17 0 0 2.2 0
Table 1 Procalcitonin and CRP
values in the vitreous humor and
in the cerebrospinal fluid for
sepsis cases and control cases
For the sepsis cases, postmortem
microbiological investigations
performed on cardiac blood
revealed the presence of K.
pneumoniae (two cases), E. coli
(two cases), and S. aureus (one
case). In three cases, postmor-
tem microbiological investiga-
tion revealed no clearly
identifiable pathogens. For the
control cases, the causes of
death are reported
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different between the sepsis group and the control group.
These results confirm those of the clinical studies per-
formed by Balci et al. [1] and Harbarth et al. [2].
Multiple organ failure of various noninfectious causes
(trauma, burn, myocardial infarction, pancreatitis) is well
known to induce a rise in inflammatory cytokine levels.
Therefore, it is not surprising that IL-6, IL-8, or TNF-α is
not appropriate to discriminate between septic or non-septic
causes of death [5, 11].
High serum procalcitonin concentrations were first
described in children with severe bacterial infections by
Assicot and co-workers, and were suggested to be a specific
marker for bacterial infection. Moreover, procalcitonin
concentrations seemed to bear a correlation with the
severity of sepsis [12].
Tsokos et al. investigated the use of procalcitonin as a
postmortem marker of sepsis and its usefulness as a
biochemical parameter in the forensic elucidation of death
due to sepsis. They analyzed postmortem blood concentra-
tion of procalcitonin in two study groups (a sepsis group
and a control group), compared with procalcitonin concen-
trations measured in antemortem blood samples. Their
results showed that, in the sepsis group, serum procalcito-
nin levels were elevated in all patients, whereas in the
control group, procalcitonin levels were not detectable in
most cases, suggesting that procalcitonin could be consid-
ered a suitable biochemical postmortem marker of sepsis.
According to the authors, measurements of procalcitonin
levels in sepsis-related fatalities seemed to be reasonable
until at least approximately 140 h after death. The authors
also emphasized that, compared to other potential biochem-
ical postmortem markers of sepsis (TNF-α, IL-6, and CRP),
procalcitonin seemed to be more stable even after repeated
freezing and thawing of the samples [4].
In the last years, several studies have been performed in
order to demonstrate the usefulness in forensic practice of
CRP and IL-6 in sepsis-related fatalities. All studies agreed
to consider high postmortem levels of these markers to be a
nonspecific indicator of an underlying inflammatory pro-
cess rather than a specific marker of sepsis.
Uhlin-Hansen investigated the CRP levels in postmor-
tem blood compared with the CRP levels measured within
the last 24 h prior to death. The results of this study showed
that postmortem CRP values in average were reduced by
35% compared to antemortem values. However, high CRP
levels in postmortem blood seemed to be a good marker for
ongoing inflammatory processes prior to death [13].
Tsokos et al. investigated the serum CRP and IL-6 levels
in sepsis-related fatalities and in a control group during the
early postmortem period, compared with CRP and IL-6
levels measured in antemortem blood samples. They found
that, in the sepsis-related fatalities, antemortem and post-
mortem CRP and IL-6 levels were significantly elevated in
all patients, whereas in the control cases, CRP and IL-6
levels measured in postmortem blood showed slight
increases, this being in only a limited number of cases.
The authors specified that several clinical conditions
associated with high IL-6 and/or CRP levels as a result of
Table 2 Significant differences between sepsis group and control group for CRP and procalcitonin
Sepsis (n=8) Control (n=10) Mann–Whitney U test
Mean (SD) Median (min–max) Mean (SD) Median (min–max)
Serum
CRP (mg/ml) 154.4 (90.7) 163 (23–272) 19.0 (46.2) 4.5 (1–150) P=0.001
Procalcitonin (ng/ml) 38.9 (73.8) 10.7 (0.03–218) 2.9 (8.7) 0.05 (0–27.7) P=0.016
TNF-α (pg/ml) 75.2 (79.2) 58.9 (2.9–249) 69.5 (182.7) 4.0 (0.08–586) P=0.076
IL-6 (pg/ml) 10,677 (26,162) 897 (81–75,296) 12,201 (35,269) 277 (16–112,403) P=0.182
IL-8 (pg/ml) 714 (1,064) 151 (79–3,115) 157 (159) 76 (0.01–399) P=0.051
Vitreous humor
CRP (mg/ml) 1.4 (2.8) 0 (0–8) 0.1 (0.32) 0 (0–1) P=0.143
Procalcitonin (ng/ml) 0.41 (0.33) 0.29 (0–0.9) 0.04 (0.11) 0 (0–0.34) P=0.005
Cerebrospinal fluid
CRP (mg/ml) 2.5 (4.2) 0.5 (0–12) 0.62 (1.4) 0 (0–4) P=0.204
Procalcitonin (ng/ml) 3.7 (8.6) 0.14 (0–25) 0.47 (1.3) 0.06 (0–4.2) P=0.788
Table 3 Correlation between vitreous humor and cerebrospinal fluid,
CRP, and procalcitonin values and serum values
Vitreous humor Cerebrospinal fluid
Spearman’s correlation
coefficient (p value)
Spearman’s correlation
coefficient (p value)
CRP 0.605 (p=0.008) 0.445 (p=0.064)
Procalcitonin 0.871 (p<0.0001) 0.309 (p=0.213)
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the systemic inflammatory response syndrome (for exam-
ple, traumas or burn injuries) should be taken into
consideration when assessing postmortem IL-6 and CRP
concentrations as biochemical postmortem markers of
sepsis [5].
Fujita et al. investigated postmortem serum CRP levels
in forensic autopsy cases of acute and non-acute death, with
special reference to the survival time and the cause of
death. They concluded that postmortem serum CRP level
can be used in forensic diagnosis in a similar manner as in
clinical practice [14].
Maeda et al. analyzed serum levels of CRP in forensic
autopsy cases with special reference to the cause of death.
They found that serum CRP was markedly higher in cases
of pneumonia and chronic renal failure, mildly to moder-
ately elevated in cases of gastrointestinal bleeding and
hypothermia, and mildly elevated in some cases of sudden
cardiac death and cerebrovascular stroke. The authors
concluded that elevated serum CRP levels in cases of
chronic renal failure may be related to the characteristics of
diseases and/or infectious complications. For pneumonia, a
markedly high serum CRP level may indicate the severity
of infection, whereas a low CRP value in some infantile
and elderly cases of pneumonia may be ascribed to an age-
dependent low inflammatory response [15].
Finally, Ishikawa et al. investigated postmortem CRP
levels in forensic autopsy cases, with special regard to
systemic inflammatory response syndrome and infectious
diseases. They observed markedly elevated serum CRP
levels in cases of delayed death due to trauma, involving
systemic inflammatory response syndrome. Markedly ele-
vated serum CRP levels were also observed in cases of fatal
bacterial infections [16].
In the present study, we also compared CRP and
procalcitonin values in serum, vitreous humor, and cere-
brospinal fluid in a series of sepsis-related fatalities and
control subjects. We did so in order to determine their
applicability in the postmortem diagnosis of death due to
sepsis. According to our results, procalcitonin values in
vitreous humor are statistically different between the sepsis
group and the control group (Table 2). Moreover, a significant
linear correlation was observed between CRP values in
serum and in cerebrospinal fluid, as well as between
procalcitonin values in serum and in vitreous humor
(Table 3). Hence, even if further studies are needed to
confirm these results, these first data suggest that the
measurement of procalcitonin in vitreous humor could be
an alternative to serum in cases where serum is not available.
This study represents a first analysis of CRP and
procalcitonin in serum, vitreous humor, and cerebrospinal
fluid in a series of sepsis-related fatalities and control
subjects. It aims to evaluate their applicability as biochem-
ical parameters of sepsis.
Astrup and Thomsen investigated postmortem blood and
liver CRP levels in a series of 50 forensic autopsy cases.
Their results showed that in cases when blood is not
available and in cases of mild to moderate putrefaction,
where bacteriological diagnosis is otherwise impossible, the
determination of liver CRP can be useful in the diagnosis of
severe infection [17].
In conclusion, the results of the present study confirm
that procalcitonin is a more reliable parameter than other
measures in the diagnosis of sepsis, thus allowing a better
differentiation between sepsis-related fatalities and non-
sepsis-related fatalities. Moreover, the determination of
vitreous procalcitonin could be an alternative to the serum
procalcitonin for the postmortem diagnosis of sepsis. Even
if further studies and investigations are required to confirm
these results, the data seem to indicate that other biological
fluids may be collected and analyzed in order to make a
postmortem diagnosis of sepsis and that vitreous procalci-
tonin might be considered a reliable alternative to the serum
procalcitonin.
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